Angela Fitch, MD, FACP, FOMA, Dipl
Visceral fat is known to produce inflammatory cytokines at higher levels, so as GLP 1s reduce this fat, the inflammatory load on the body decreases
Special Populations and Considerations Not everyone responds identically to these medications
So those individuals may not appear very overweight, but they have a lot of what we call central weight adiposity or visceral fat, said Jensen, who cofounded the Nonalcoholic Fatty Liver Disease (NAFLD) Clinic at the University of Colorado Anschutz Medical Campus with Amanda Wieland, MD, of gastroenterology and hepatology after joining the CU School of Medicine faculty in 2016
In an email to Pharmaceutical Technology , Mochi Healths CEO Dr Myra Ahmad said: [We] will continue to provide compounded GLP-1RAs, even after the FDA has resolved the semaglutide shortage